You can buy or sell BPMC and other stocks, options, ETFs, and crypto commission-free!
Blueprint Medicines Corporation Common Stock, also called Blueprint Medicines, is a precision therapy company, which focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Read More Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 10
Edited Transcript of BPMC earnings conference call or presentation 9-May-19 12:30pm GMT
Q1 2019 Blueprint Medicines Corp Earnings Call CAMBRIDGE May 10, 2019 (Thomson StreetEvents) -- Edited Transcript of Blueprint Medicines Corp earnings conference call or presentation Thursday, May 9, 2019 at 12:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Anthony L. Boral Blueprint Medicines Corporation - Chief Medical Off...
Yahoo FinanceApr 30
See what the IHS Markit Score report has to say about Blueprint Medicines Corp.
Blueprint Medicines Corp NASDAQ/NGS:BPMC View full report here! Summary Bearish sentiment is low Economic output in this company's sector is expanding Bearish sentiment Short interest | Positive Short interest is low for BPMC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flow ETF/Index ownership | Neutral ...
Expected Jul 31, Pre-Market